pI: 6.8319 |
Length (AA): 560 |
MW (Da): 59917 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
74 | 560 | 1sky (B) | 21 | 479 | 24.00 | 0 | 1 | 1.04 | -0.53 |
82 | 554 | 2ck3 (D) | 11 | 475 | 81.00 | 0 | 1 | 1.89 | -1.49 |
56 | 556 | 5dn6 (A) | 5 | 484 | 23.00 | 0 | 1 | 1.09744 | 0.28 |
81 | 554 | 5dn6 (D) | 5 | 471 | 76.00 | 0 | 1 | 1.77723 | -0.9 |
81 | 554 | 2ck3 (D) | 10 | 475 | 81.00 | 0 | 1 | 1.82523 | -0.88 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 Oocyst. | Fritz HM |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_127099)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | ArthCp029 | ATPase beta chain |
Arabidopsis thaliana | AT5G08680 | ATP synthase subunit beta-3 |
Arabidopsis thaliana | AT5G08690 | ATP synthase subunit beta-2 |
Arabidopsis thaliana | AT5G08670 | ATP synthase subunit beta-1 |
Arabidopsis thaliana | ArthCp026 | NADH dehydrogenase 27 kDa subunit |
Babesia bovis | BBOV_IV005830 | ATP synthase F1 beta chain, putative |
Brugia malayi | Bm1_45960 | ATP synthase beta chain, mitochondrial precursor, putative |
Candida albicans | CaO19.5653 | beta subunit of mitochondrial F1F0-ATPase |
Candida albicans | CaO19.13098 | beta subunit of mitochondrial F1F0-ATPase |
Caenorhabditis elegans | CELE_C34E10.6 | Protein ATP-2 |
Cryptosporidium hominis | Chro.20148 | ATP synthase beta chain, mitochondrial precursor |
Cryptosporidium parvum | cgd2_1360 | ATP synthase beta chain, mitochondrial precursor, putative |
Chlamydia trachomatis | CT_669 | type III secretion system ATPase |
Dictyostelium discoideum | DDB_G0269916 | ATP synthase beta chain, mitochondrial |
Drosophila melanogaster | Dmel_CG11154 | ATP synthase-beta |
Drosophila melanogaster | Dmel_CG5389 | male sterile (3) 72Dt |
Escherichia coli | b3732 | F1 sector of membrane-bound ATP synthase, beta subunit |
Echinococcus granulosus | EgrG_000752000 | ATP synthase subunit beta mitochondrial |
Echinococcus multilocularis | EmuJ_000752000 | ATP synthase subunit beta, mitochondrial |
Homo sapiens | ENSG00000110955 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
Leishmania braziliensis | LbrM.25.1150 | ATPase beta subunit, putative |
Leishmania donovani | LdBPK_251210.1 | ATP synthase subunit beta, mitochondrial, putative |
Leishmania infantum | LinJ.25.1210 | ATPase beta subunit, putative |
Leishmania infantum | LinJ.25.2580 | ATPase beta subunit, putative |
Leishmania major | LmjF.25.1180 | ATPase beta subunit, putative |
Leishmania major | LmjF.25.1170 | ATPase beta subunit, putative |
Leishmania mexicana | LmxM.25.1170 | ATPase beta subunit, putative |
Leishmania mexicana | LmxM.25.1180 | |
Loa Loa (eye worm) | LOAG_08048 | ATP synthase subunit beta |
Mycobacterium leprae | ML1145 | PROBABLE ATP SYNTHASE BETA CHAIN ATPD |
Mus musculus | ENSMUSG00000025393 | ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
Mycobacterium tuberculosis | Rv1310 | Probable ATP synthase beta chain AtpD |
Mycobacterium ulcerans | MUL_3954 | F0F1 ATP synthase subunit beta |
Neospora caninum | NCLIV_025670 | ATP synthase subunit beta (EC 3.6.3.14), related |
Oryza sativa | 4351757 | Os12g0207500 |
Oryza sativa | 3131461 | ATP synthase epsilon chain |
Oryza sativa | 3131459 | NADH dehydrogenase 27 kDa subunit |
Oryza sativa | 3131462 | ATPase beta chain |
Oryza sativa | 4324151 | Os01g0685800 |
Oryza sativa | 9271553 | Os01g0791150 |
Oryza sativa | 4339546 | Os05g0553000 |
Plasmodium berghei | PBANKA_1450300 | ATP synthase subunit beta, mitochondrial |
Plasmodium falciparum | PF3D7_1235700 | ATP synthase subunit beta, mitochondrial |
Plasmodium knowlesi | PKNH_1455400 | ATP synthase subunit beta, mitochondrial, putative |
Plasmodium vivax | PVX_100735 | ATP synthase subunit beta, mitochondrial, putative |
Plasmodium yoelii | PY00963 | ATP synthase F1, beta subunit |
Saccharomyces cerevisiae | YJR121W | F1F0 ATP synthase subunit beta |
Schistosoma japonicum | Sjp_0059730 | ko:K01549 ATP synthase [EC3.6.3.14], putative |
Schistosoma mansoni | Smp_038100 | ATP synthase beta subunit |
Schmidtea mediterranea | mk4.001599.04 | ATP synthase subunit beta, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.3.1130 | ATP synthase beta chain, mitochondrial precursor,ATP synthase F1, beta subunit |
Trypanosoma brucei | Tb927.3.1380 | ATP synthase subunit beta, mitochondrial |
Trypanosoma cruzi | TcCLB.509233.180 | ATP synthase subunit beta, mitochondrial, putative |
Toxoplasma gondii | TGME49_261950 | ATP synthase beta subunit ATP-B |
Treponema pallidum | TP0402 | flagellum-specific ATP synthase (fliI) |
Theileria parva | TP01_0389 | ATP synthase F1, beta chain, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0689 | ATP synthase F0F1 subunit beta |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1332 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.3.1380 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1380 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1380 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.1380 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3732 | Escherichia coli | non-essential | goodall |
CELE_C34E10.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C34E10.6 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C34E10.6 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C34E10.6 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1450300 | Plasmodium berghei | Slow | plasmo |
TGME49_261950 this record | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mycobacterium tuberculosis | Probable ATP synthase beta chain AtpD | Compounds | References |
Saccharomyces cerevisiae | F1F0 ATP synthase subunit beta | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable ATP synthase alpha chain AtpA | 549 aa | 24.6% | 495 aa | Compounds | References |
4 literature references were collected for this gene.